Emerging treatments in alopecia

@article{FaltoAizpurua2014EmergingTI,
  title={Emerging treatments in alopecia},
  author={Leyre A Falto-Aizpurua and Sonal Choudhary and Antonella Tosti},
  journal={Expert Opinion on Emerging Drugs},
  year={2014},
  volume={19},
  pages={545 - 556}
}
Introduction: Alopecia is a common concern encountered in the medical practice. Treatment approach varies according to the type and severity of alopecia. However, available treatment options have limited efficacy and several adverse effects. Presently, there are different treatment options being studied to overcome these limitations. Additionally, cellular pathways involved in the pathophysiology of alopecia are further being clarified to potentially target pathogenic molecules. Areas covered… 
Safety concerns when using novel medications to treat alopecia
TLDR
This review summarizes the safety concerns when using novel therapeutic modalities such as JAK inhibitors, hair transplantation, mesotherapy, oral minoxidil, platelet-rich plasma, microneedling, and 5α-reductase inhibitors for treating hair loss.
A Comment on JAK Inhibitors for Treatment of Alopecia Areata
TLDR
A meta-analysis of published trials on the treatment of alopecia areata came to the conclusion that most have been reported poorly and so small that any important clinical benefits are inconclusive, and considering the possibility of spontaneous remission, the options of not being treated or depending on individual preference, and of wearing a wig may be alternative ways of dealing with the condition.
Therapeutic options in frontal fibrosing alopecia
TLDR
The evidence available to date gives some guidance as to potential effective treatment approaches for FFA patients which include 5-alpha-reductase inhibitors, intralesional steroids, hydroxychloroquine, topical calcineurin inhibitors, excimer laser, pioglitazone, oral tetracyclines and minoxidil.
Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
TLDR
The complexity of pathogenesis offers opportunities for the development of novel targeted therapies and new treatment opportunities based on the results of genome-wide association studies that implicate T cell and natural killer cell activation pathways are paving the way to new approaches in future clinical trials.
Successful Management of Treatment-Resistant Alopecia Areata with Platelet Rich Plasma: A Case Series
TLDR
Autologous PRP is safe and effective in treatment-resistant forms of AA demonstrated in many case reports; therefore it deserves further study with randomized, placebo-controlled trials.
Cosmetic Procedures in the Treatment of Alopecia
TLDR
Various procedures that are being applied for different types of alopecia including mesotherapy, microneedling, platelet‐rich plasma, low‐level light therapy, and stem‐cell therapy with variable outcomes are reviewed in this chapter.
Treatment of corticosteroid-refractory alopecia totalis with oral tacrolimus
TLDR
It is shown that in young patients with no other past medical history of relevance, whereby conventional treatment modalities are ineffective and quality of life has been severely impacted by the disease, these patients may benefit from consideration for immunosuppressive therapy such as tacrolimus as an efficacious and durable treatment option.
Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
TLDR
In conclusion, superficial cryotherapy is an effective and safe therapeutic modality for AA, especially when the treatment interval is 2 weeks or less and in the first occurrence of the disease, the therapeutic outcome is superior.
A Proposal of an Effective Platelet-rich Plasma Protocol for the Treatment of Androgenetic Alopecia
TLDR
PRP together with a periodical application protocol can be considered effective as a coadjuvant therapy in patients who no longer respond to pharmacological treatments.
Nanotechnology advances for hair loss.
TLDR
Some recent studies involving the nanosystems developed for the pharmacological treatment of alopecia are presented, highlighting how each system represents an improvement in relation to conventional drug products and the future perspectives of these new technologies in reaching the market.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 91 REFERENCES
New investigational drugs for androgenetic alopecia
TLDR
The future holds more effective topical treatments with less systemic side effects, prostaglandin analogs and antagonists, medications which act through the Wnt signaling pathway, stem cells for hair regeneration, platelet-rich plasma (PRP) and more effective ways of transplanting hair.
Treatment options for alopecia: an update, looking to the future
TLDR
Current treatment options for the most common forms of hair loss are summarized, and the literature on treatment options to emerge over the 3 years since the release of the first edition of this article is updated.
A Study to Evaluate the Efficacy of Various Topical Treatment Modalities for Alopecia Areata
TLDR
Among the various topical modalities used for the treatment of AA, the most effective are the Intralesional and Topical steroids with no significant side-effects.
THERAPEUTIC HOTLINE: Effectiveness of the association of cetirizine and topical steroids in lichen planus pilaris – an open‐label clinical trial
TLDR
The cases indicate that a combined therapy of topical steroid with CTZ can be a safe and effective choice even in severe cases of lichen planus pilaris, so often refractory to the therapy.
Interventions for alopecia areata.
TLDR
No RCTs were found on the use of diphencyprone, dinitrochlorobenzene, intralesional corticosteroids or dithranol although they are commonly used for the treatment of alopecia areata.
Placebo-controlled oral pulse prednisolone therapy in alopecia areata.
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
TLDR
In this first comparison published to date, both PAX and CC offer efficacious protection against hair loss, in particular when docetaxel is administered in a 3-weekly interval.
Potential targets in the discovery of new hair growth promoters for androgenic alopecia
TLDR
It is unlikely that single targeted agents will be sufficient for treating Androgenic alopecia, and therefore, it would be a challenge to obtain compounds with multiple activities.
Use of Pioglitazone in Patients with Lichen Planopilaris
TLDR
Thiazolidinediones, being PPARγ agonists, could be a new promising venue of LPP treatment because of decreased tissue expression of peroxisome proliferator-activated receptor (PPAR) γ in lichen planopilaris.
Histopathologic features of alopecia areata: a new look.
TLDR
The histopathologic features of alopecia areata depend on the stage of the current episode, and should be suspected when high percentages of telogen hairs or miniaturized hairs are present, even in the absence of a peribulbar lymphocytic infiltrate.
...
1
2
3
4
5
...